Real-World data on tezepelumab for severe asthma released

NCT ID NCT07013760

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at medical records of 420 people with severe asthma in Spain who were given tezepelumab after it was approved. The goal was to see how well the drug works in real life, not just in controlled trials. Researchers tracked things like asthma attacks, symptoms, and patient background to understand the drug's true impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Research Site

Andalucia, Spain
Research Site

C. Valenciana, Spain
Research Site

C. Y Leon, Spain
Research Site

Cantabria, Spain
Research Site

Castilla La Mancha, Spain
Research Site

Cataluna, Spain
Research Site

Extremadura, Spain
Research Site

Galicia, Spain
Research Site

Islas Canarias, Spain
Research Site

Madrid, Spain
Research Site

Navarra, Spain
Research Site

Pais Vasco, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.